Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$2.62
-0.94%
Mkt Cap $242.80M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+319.8%
Consensus $11.00 vs current $2.62
NASDAQ·Healthcare·Biotechnology
$2.62
-0.94%
Mkt Cap $242.80M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+319.8%
Consensus $11.00 vs current $2.62